Citation Tools
PDFImmune cell therapies and immune cell engineering
Original research
Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML